Skip to main content

Oxford’s Collins set for Discovery Lecture

Mar. 28, 2013, 9:10 AM

Sir Rory Collins, MBBS, professor of Medicine and Epidemiology at the University of Oxford, England, will deliver the next Flexner Discovery Lecture on Thursday, April 4.

His lecture, “Size matters: the need for large-scale population studies,” will begin at 4 p.m. in 208 Light Hall. It is sponsored by the Oates Institute for Experimental Therapeutics.

Sir Rory Collins, MBBS

Collins, the co-director of the Clinical Trial Service Unit and Epidemiological Studies Unit at Oxford, is known for the establishment of large-scale epidemiological studies of the causes, prevention and treatment of heart attacks, other vascular disease and cancer. He has also developed approaches to combine results from related studies, called “meta-analyses.”

In 2005, Collins became principal investigator and chief executive of the UK Biobank, a prospective study of 500,000 British people, aged 40-69. Enrollment for the UK Biobank took place over four years starting in 2006, and the volunteers will be followed for at least 25 years.

The long-term study is investigating the contributions of genetics and environmental exposures (such as nutrition, lifestyle and medications) to the development of disease.

Collins is a Fellow of the UK Academy of Medical Sciences and of the Royal College of Physicians. He was knighted in 2011 for his services to science.

For a complete schedule of the Flexner Discovery Lecture series and archived video of previous lectures, go to http://www.mc.vanderbilt.edu/discoveryseries.

Recent Stories from VUMC News and Communications Publications

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

Momentum

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Hope

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Vanderbilt Nurse

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

more